Hemp pioneer Geoff Whaling to join Canopy Growth USA as Strategic Advisor, Hemp and CBD in addition to being the co-Founder and President of Hemp Developments LLC. March 21, 2019 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce today it has acquired AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, that has been at the forefront of hemp advocacy and building a vibrant hemp sector in the USA. The acquisition will accelerate Canopy Growth’s entry into key American jurisdictions as regulations surrounding the full use of hemp as a…

March 20, 2019 SMITHS FALLS, ON and VICTORIA, BC – Canopy Growth Corporation (TSX:WEED, NYSE: CGC) (“Canopy Growth” or the “Company”) and HollyWeed Manufacturing & Extracts Inc. are pleased to announce today they have entered into a multi-year processing and extraction agreement. HollyWeed North Cannabis Inc., the parent company of HollyWeed Manufacturing & Extracts Inc., is a female-led, LGBTQ2-positive company based in British Columbia that operates several subsidiaries specializing in the growth, manufacturing, licensing, and production of cannabis and other pharmaceutical grade products. Under the terms of the two-year agreement, HollyWeed Manufacturing & Extracts Inc. will process dried cannabis provided…

March 19, 2019 SMITHS FALLS, ON and LOS ANGELES, CA – Canopy Growth Corporation (“Canopy”) (TSX:WEED, NYSE: CGC) (“Canopy Growth” or the “Company”), a world-leading, diversified cannabis company and OG DNA Genetics (“DNA”), a globally recognized cannabis brand, are pleased to announce today they have signed an agreement to extend and expand upon their previously announced partnership through to 2024. With this newly signed agreement, Canopy Growth and DNA have extended their partnership beyond Canada and Jamaica and have committed to bringing DNA’s world-renowned genetics to a soon-to-be disclosed European market. Canopy Growth and DNA entered into their first agreement…

New study led by NEEKA Health Canada will test if CBD-based therapies can reduce the severity of post-concussion brain disorders in former NHL players March 2, 2019 TORONTO & SMITHS FALLS, ON — NHL Alumni Association (NHLAA), NEEKA Health Canada and Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) are pleased to announce a transformative clinical research partnership that will investigate the efficacy of cannabinoids as an integral part of a novel treatment for post-concussion neurological diseases in former NHL players. A substantial number of these high performing, former professional athletes have developed impairments as a result of…

March 1, 2019 TORONTO & SMITHS FALLS, ON — We would like to invite you to join us as NEEKA Healthcare Canada and Canopy Growth (TSX:WEED, NYSE:CGC) unveil a transformative clinical research initiative in partnership with the NHL Alumni Association, a passionate advocate for improving the health and quality of life for all former NHL players. There will be a press conference featuring Glenn Healy, Executive Director with the NHLAA and former NHL player, Dr. Amin Kassam from NEEKA Healthcare Canada, and from Canopy Growth, Dr. Mark Ware, Chief Medical Officer and Hilary Black, Chief Advocacy Officer. Additional former NHL…

Martha Stewart to join as advisor on hemp-derived CBD products February 28, 2019 SMITHS FALLS, ON and NEW YORK — Canopy Growth Corporation (“Canopy Growth” or “the Company”) (TSX:WEED, NYSE:CGC) and Sequential Brands Group, Inc. (“Sequential”) (Nasdaq:SQBG) announced today that Martha Stewart has joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories. With decades of success in publishing, broadcasting, online and merchandising, Martha Stewart has firmly cemented herself as one of the most well-respected businesswomen in the United States. Along with a deep understanding of what…

February 22, 2019 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce the appointment of Dr. Danial Schecter as Director of Global Medical Services. Dr. Schecter is widely recognized as an expert in the clinical use of medical cannabis and will use his experience to expand the Company’s network of partner healthcare clinics and support doctors and patients who understand the value of cannabis as medicine. “I have had the honour of serving a range of patients who, after exhausting traditional pharmaceutical approaches, have reported the remarkable benefits of therapeutic cannabis,”…

February 20, 2019 SMITHS FALLS, ON – Canopy Growth Corporation (TSX:WEED) (NYSE: CGC) (“Canopy Growth” or “the Company) filed its Amended and Restated Management Discussion and Analysis for the three and nine months ended December 31, 2018 (“Amended MD&A”) to correct the Adjusted EBITDA1 in the original MD&A for the nine months ended December 31, 2018 filed on February 14, 2019 (the “Original MD&A”), as follows. The correction of the Adjusted EBITDA loss for the nine months ended December 31, 2018 from $69,006,000 to $155,154,000. The correction was made due to a formula error in the spreadsheet supporting the year…

Laval (Québec) & Smiths Falls (Ontario) Canada – February 21, 2019 – Alimentation Couche-Tard Inc. (“Alimentation-Couche-Tard”) (TSX: ATD.A) (TSX: ATD.B) has entered into a multi-year agreement with Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED, NYSE: CGC). Subsequent to this newly formed strategic partnership, and pending the results of a public-consultation process, Alimentation Couche-Tard is excited to announce it has entered into a trademark license agreement with one of the winners of the Alcohol and Gaming Commission of Ontario’s (the “AGCO”) Expression of Interest Application Lottery, who will operate a “Tweed” branded retail store in London, Ontario, once the process is…

February 7, 2019 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED, NYSE: CGC) is pleased to announce that it intends to increase its total investment in Canopy Rivers Inc. (“Canopy Rivers”) (TSXV: RIV) by $30 million (CDN). The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers (the “Subordinate Voting Shares”) concurrent with Canopy Rivers bought deal offering of Subordinate Voting Shares for gross proceeds of approximately $55 million. This investment is being co-led by CIBC Capital Markets and Eight Capital and is expected to…

High-quality medical cannabis available today in Polish pharmacies; UK presence positions Spectrum to lead in a key emerging market. January 21, 2019 Smiths Falls, Canada, Oxford, UK, Toruń, Poland – Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) (“Canopy Growth” or the “Company”) is pleased to update key European progress in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients throughout the continent. United Kingdom In the United Kingdom the Company has formed Spectrum Biomedical UK, a new company focused on providing access…